<DOC>
	<DOC>NCT01169168</DOC>
	<brief_summary>In this study patients with 1. chronicle liver diseases - primary biliary cirrhosis - primary sclerosing cholangitis - alcoholic liver cirrhosis - hepatitis b or C - Wilson's disease - cryptogenic cirrhosis 2. Septic Inflammatory Response Syndrome (SIRS) - sepsis - septic shock 3. patients after lysis should be included Blood samples will be gathered from the patients to measure fibrinogen with 5 different methods. The methods are: - Clauss fibrinogen - PT-Derived fibrinogen - immunoturbidimetric method - heat-precipitated fibrinogen - Schulz fibrinogen The result of these tests will be correlated with laboratory values which are gathered in routine and the clinical outcomes.</brief_summary>
	<brief_title>Measurement of Fibrinogen in Patients With Systemic Inflammatory Response Syndrome (SIRS), Sepsis or Chronicle Liver Disease on Intensive Care Units (ICU)</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Systemic Inflammatory Response Syndrome</mesh_term>
	<criteria>SIRS sepsis septic shock chronicle liver disease (MELDScore &gt;10) patient after lysis patient agrees no agreement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>fibrinogen</keyword>
	<keyword>SIRS</keyword>
	<keyword>sepsis</keyword>
	<keyword>liver disease</keyword>
	<keyword>chronic liver disease</keyword>
	<keyword>septic shock</keyword>
</DOC>